Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 212 Results Clear All
Scientists say it may be possible to drive the virus into “deep latency” by targeting the cellular process of transcription, by which lingering HIV cells continue to produce viral components.
News Release Research (Publication) HIV/AIDS Virology Ott Lab
Virologist Sukrit Silas hopes to turn bacteria-killing viruses into new therapies that hold promise against even the most persistent superbugs.
News Release Profile Virology
The prize will be awarded annually to a Gladstone scientist who has made breakthrough discoveries in brain research; funds will help advance scientific discoveries from the lab to the clinic.
Awards News Release Alzheimer’s Disease Neurological Disease Huang Lab Aging Human Genetics
Gladstone scientists undertake a major effort to examine the diversity of retrons, bacterial defense systems that can be leveraged for precise gene editing
News Release Research (Publication) Data Science and Biotechnology Shipman Lab
Scientists at Gladstone Institutes develop a streamlined and rapid way to engineer bacteria-fighting viruses known as phages
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.
Institutional News News Release
Tcheandjieu is one of 10 scholars nationwide selected as an emerging leader who’s shaping the future of health and medicine.
Awards News Release Heart Failure Data Science and Biotechnology Tcheandjieu Lab AI Big Data
A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.
News Release Research (Publication) COVID-19 Neurological Disease Virology Akassoglou Lab
Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies
News Release Research (Publication) Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene Editing
Researchers identify a root cause of developmental delays that result from brain bleeds in premature infants, opening a path for new therapeutic strategies to counter long-term health risks
News Release Research (Publication) Neurological Disease Center for Neurovascular Brain Immunology Akassoglou Lab
Scientists at Gladstone develop a more efficient way to make several, precise edits simultaneously to human cells
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
Eyquem, an affiliate investigator at Gladstone Institutes, is working to enhance the efficiency of CAR-T therapy, a cancer treatment that modifies T cells to target cancer cells.
Awards News Release Cancer Eyquem Lab
Two new tools created at Gladstone Institutes allow scientists to study DNA at single-molecule resolution using fewer cells than previously required, with clear applications for cancer and many other diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Genomics Human Genetics
A new study in Nature Genetics expands our understanding of immune regulation and autoimmunity—with findings that could also be used in the development of cancer immunotherapies.
News Release Autoimmune Diseases Cancer Genomic Immunology Parker Institute for Cancer Immunotherapy Marson Lab Pollard Lab Ye Lab AI CRISPR/Gene Editing
A team of researchers from Gladstone Institutes and UC San Francisco combined high-throughput experiments and machine learning to analyze more than 100,000 sequences in human brain cells.
News Release Research (Publication) Data Science and Biotechnology Pollard Lab AI Big Data Developmental Biology Disease Models Genomics Human Genetics
